Oct 26 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2021 Sep 30, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.33 2.09 4.80
(+11.7 pct) (-8.4 pct) (+12.7 pct)
Operating 442 mln 320 mln 800 mln
(+37.9 pct) (-0.2 pct) (+26.5 pct)
Recurring 444 mln 325 mln 800 mln
(+36.2 pct) (+1.4 pct) (+22.4 pct)
Net 301 mln 200 mln 540 mln
(+49.9 pct) (-9.2 pct) (+29.4 pct)
EPS 73.58 yen 48.06 yen 131.91 yen
Ann Div 15.00 yen 15.00 yen
-Q2 div NIL NIL
-Q4 div 15.00 yen 15.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T